...
首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >Orthogonal dual molecularly imprinted polymer-based plasmonic immunosandwich assay: A double characteristic recognition strategy for specific detection of glycoproteins
【24h】

Orthogonal dual molecularly imprinted polymer-based plasmonic immunosandwich assay: A double characteristic recognition strategy for specific detection of glycoproteins

机译:正交的双分子印迹聚合物基等级ImmunoSandwich测定:糖蛋白特异性检测的双重特征识别策略

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Sensitive and specific detection methods are critical to the detection of glycoproteins. Immunoassay has been a powerful tool for this purpose, in which antibodies or their mimics particularly molecularly imprinted polymers (MIPs) are used for specific recognition. Epitope and glycan are two structure features of a glycoprotein. However, immunoassays based on simultaneous recognition towards the two characteristics have been scarcely explored so far. Herein we present a new strategy called orthogonal dual molecularly imprinted polymer-based plasmonic immunosandwich assay (odMIP-PISA). It relies on double recognition towards a target glycoprotein by two different types of MIPs, using epitope-imprinted gold nanoparticles (AuNPs)-coated slide as capturing substrate to recognize the peptide epitope and glycans-imprinted Raman-active silver nanoparticles as labeling nanotags to recognize the glycans. Carcinoembryonic antigen (CEA), a routinely used marker for colon cancer, was used as a test glycoprotein. The orthogonal double recognition apparently improved the specificity, reducing the maximum cross-reactivity from 14.4% for epitope recognition and 15.2% for glycan recognition to 8.2% for double recognition. Meanwhile, the plasmonic nanostructure-based Raman detection provided ultrahigh sensitivity, yielding a limit of detection of 5.56 x 10(-)(14) M (S/N = 10). Through measuring the CEA level in human serum, this method permitted differentiation of colon cancer patient from healthy individual. Compared with the traditional immunoassay, odMIP-PISA exhibited multiple advantages, including simplified procedure (6 steps), speed (30 min), reduced cost, and so on. Therefore, this new approach holds great promise in many applications particularly clinical diagnosis.
机译:敏感和特异性检测方法对糖蛋白的检测至关重要。免疫测定对于此目的是一种强大的工具,其中抗体或其模仿特别是分子印迹聚合物(MIPS)用于特异性识别。表位和聚糖是糖蛋白的两个结构特征。然而,到目前为止,基于同时识别两个特征的免疫测定几乎没有探索。在此,我们提出了一种新的策略,称为正交双重分子印迹聚合物基质的等离子体免疫溶症测定法(ODMIP-PISA)。它依赖于通过两种不同类型的MIPS向靶糖蛋白的双重识别,使用表位印迹金纳米颗粒(AUNP)涂覆的载玻片作为捕获基底以识别肽表位和聚糖印迹拉曼 - 活性银纳米粒子,以识别标记纳米块聚糖。癌胚抗原(CEA)是用于结肠癌的常用标记,用作试验糖蛋白。正交的双重识别显然改善了特异性,从表位识别的14.4%降低了最大交叉反应性,甘然油识别为8.2%的15.2%以进行双重识别。同时,基于等离子体纳米结构的拉曼检测提供了超高敏感性,产生了5.56×10( - )(14)m(S / N = 10)的检测限。通过测量人体血清中的CEA水平,该方法允许从健康个体中分化结肠癌患者。与传统的免疫测定相比,ODMIP-PIPA表现出多种优点,包括简化的程序(6步),速度(30分钟),降低成本等。因此,这种新方法在许多应用中具有很大的希望,特别是临床诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号